Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Aslan Pharmaceuticals
Scientific Title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy